BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19234139)

  • 21. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal gammopathy: natural history studied with a retrospective approach.
    Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
    Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant transformation of monoclonal gammopathy of undetermined significance].
    Decaux O; Avet-Loiseau H; Grosbois B
    Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
    Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy-associated pure red cell aplasia.
    Korde N; Zhang Y; Loeliger K; Poon A; Simakova O; Zingone A; Costello R; Childs R; Noel P; Silver S; Kwok M; Mo C; Young N; Landgren O; Sloand E; Maric I
    Br J Haematol; 2016 Jun; 173(6):876-83. PubMed ID: 26999424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
    Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
    Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The monoclonal gammopathies.
    Kyle RA
    Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
    Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
    Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F; Thiry C; Willems D
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Curr Hematol Malig Rep; 2010 Apr; 5(2):62-9. PubMed ID: 20425398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
    Lee WS; Singh G
    Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
    Ansari AA; Tipu HN; Ahmed D; Farhan M
    Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria.
    Belouni R; Allam I; Cherguelaine K; Berkani L; Belaid B; Berkouk Y; Nekkal S; Saidani M; Belhani M; Ghaffor M; Djidjik R
    Curr Res Transl Med; 2020 Apr; 68(2):67-70. PubMed ID: 31761679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monoclonal gammopathies--from MGUS to myeloma].
    Hess U; Heijnen IA
    Ther Umsch; 2004 Feb; 61(2):161-7. PubMed ID: 15018400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monoclonal gammopathy--multiple myeloma].
    Dietzfelbinger H
    MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.